Global Bioenergies SA
Global Bioenergies SA is in the process of liquidation. Previously, the company was engaged in the development of a process for converting plant-based feedstocks into isobutene used in the cosmetic and aviation fuel industry. The company was incorporated in 2008 and is headquartered in Évry, France.
Global Bioenergies SA (1DK) - Net Assets
Latest net assets as of December 2024: €1.69 Million EUR
Based on the latest financial reports, Global Bioenergies SA (1DK) has net assets worth €1.69 Million EUR as of December 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€9.65 Million) and total liabilities (€7.96 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €1.69 Million |
| % of Total Assets | 17.54% |
| Annual Growth Rate | -23.54% |
| 5-Year Change | -81.67% |
| 10-Year Change | N/A |
| Growth Volatility | 69.58 |
Global Bioenergies SA - Net Assets Trend (2018–2024)
This chart illustrates how Global Bioenergies SA's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Global Bioenergies SA (2018–2024)
The table below shows the annual net assets of Global Bioenergies SA from 2018 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €1.69 Million | -83.74% |
| 2023-12-31 | €10.41 Million | +36.06% |
| 2022-12-31 | €7.65 Million | -59.02% |
| 2021-12-31 | €18.66 Million | +102.13% |
| 2020-12-31 | €9.23 Million | -37.65% |
| 2019-12-31 | €14.81 Million | +74.71% |
| 2018-12-31 | €8.48 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Global Bioenergies SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 6270159300.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €7.55 Million | 446.31% |
| Total Equity | €1.69 Million | 100.00% |
Global Bioenergies SA Competitors by Market Cap
The table below lists competitors of Global Bioenergies SA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
ADMIRAL GROUP - Dusseldorf Stock Exchang
DU:FLN
|
$369.72K |
|
Wingara AG Ltd
AU:WNR
|
$369.72K |
|
Jubilant Flame International Ltd
OTCQB:JFIL
|
$369.74K |
|
First Robinson Financial Corporation
PINK:FRFC
|
$369.81K |
|
Aoxing Pharmaceutical Company Inc
PINK:AOXG
|
$369.49K |
|
Ready Set Gold Corp
PINK:RDYFF
|
$369.35K |
|
Hydrocarbon Dynamics Limited
PINK:PYMOF
|
$369.32K |
|
BANKUNITED
BE:BNU
|
$369.28K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Global Bioenergies SA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 10,407,176 to 1,692,414, a change of -8,714,762 (-83.7%).
- Net loss of 5,861,000 reduced equity.
- Other factors decreased equity by 2,853,762.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-5.86 Million | -346.31% |
| Other Changes | €-2.85 Million | -168.62% |
| Total Change | €- | -83.74% |
Book Value vs Market Value Analysis
This analysis compares Global Bioenergies SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.25x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.01x to 0.25x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | €1.67 | €0.02 | x |
| 2019-12-31 | €1.67 | €0.02 | x |
| 2020-12-31 | €0.90 | €0.02 | x |
| 2021-12-31 | €1.24 | €0.02 | x |
| 2022-12-31 | €0.50 | €0.02 | x |
| 2023-12-31 | €0.57 | €0.02 | x |
| 2024-12-31 | €0.09 | €0.02 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Global Bioenergies SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -346.31%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -1625.06%
- • Asset Turnover: 0.04x
- • Equity Multiplier: 5.70x
- Recent ROE (-346.31%) is below the historical average (-144.91%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | -160.88% | -1970.50% | 0.03x | 3.00x | €-14.48 Million |
| 2019 | -86.04% | -10846.34% | 0.00x | 1.89x | €-14.22 Million |
| 2020 | -118.16% | -17087.47% | 0.00x | 2.79x | €-11.83 Million |
| 2021 | -63.08% | -11663.96% | 0.00x | 1.70x | €-13.64 Million |
| 2022 | -156.71% | -1718.39% | 0.03x | 2.82x | €-12.75 Million |
| 2023 | -83.18% | -266.41% | 0.18x | 1.75x | €-9.70 Million |
| 2024 | -346.31% | -1625.06% | 0.04x | 5.70x | €-6.03 Million |
Industry Comparison
This section compares Global Bioenergies SA's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Global Bioenergies SA (1DK) | €1.69 Million | -160.88% | 4.70x | $369.68K |
| Hanna Capital Corp (04U1) | $-79.29K | 0.00% | 0.00x | $116.52K |
| WESTMINSTER RES (08W) | $4.66 Million | -31.33% | 0.12x | $5.16 Million |
| Axonics Inc (0I3) | $570.14 Million | -10.47% | 0.16x | $3.29 Billion |
| GIEAG Immobilien AG (2GI) | $41.80 Million | 40.21% | 8.93x | $15.57K |
| 2invest AG (2INV) | $82.61 Million | -2.29% | 0.06x | $13.67 Million |
| PT Central Proteina Prima Tbk (4PT) | $3.42 Trillion | 11.74% | 1.00x | $6.90 Million |
| DGH Deutsche Grundwert Holding AG (5TR) | $0.00 | 0.00% | 0.00x | $18.45K |
| SOFTCHOICE CORP. (90Q) | $58.23 Million | -19.76% | 10.01x | $470.36 Million |
| ALBA SE (ABA) | $142.95 Million | 5.25% | 0.45x | $5.10 Million |